News

Hikma Pharmaceuticals USA (OTCPK:HKMPF) plans to invest $1 billion through 2030 to boost its U.S. manufacturing and R&D.
Hikma Pharmaceuticals USA has started work on a $1 billion investment that includes an expansion of its West Side facilities.
A pharmaceutical company is expanding in Lexington’s Coldstream Research Campus by putting $80 million toward additional ...
In April this year, the United States Food and Drug Administration (US FDA) had conducted a current Good Manufacturing Practices (cGMP) inspection at the manufacturing facility of Time-Cap ...
To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...
Ferring Pharmaceutical officially opened its new 12,000-square-foot gene therapy manufacturing facility located within its US ...
Ferring USA in Parsippany employs more than 900 individuals. Ferring Pharmaceuticals officially opened doors to its state-of-the-art gene therapy manufacturing facility in Parsippany June 17, 2025.
As the pharma sector braces for sector-specific tariffs from President Trump, what could the impact look like on supply ...
The Middle East life sciences market will grow to $36bn by 2028, driven by R&D investments, digital health adoption, and ...
SINGAPORE] Alcon, a Swiss-American pharmaceutical and medical device company specialising in eye care products, opened its ...